Featured Article

Translated article Glucagon Like Peptide 1 Agonists for Treating refreshing makeover

Heather Aug 05, 2026

Current Perspectives on GLP

Translated article Glucagon Like Peptide 1 Agonists for Treating
Translated article Glucagon Like Peptide 1 Agonists for Treating

This review provides a comprehensive and scholarly examination of glucagon-like peptide-1 receptor (GLP-1R) agonists , tracing their evolution from glycemic control agents in diabetes mellitus (DM) to multifaceted therapeutics with expanding ...

Cardiovascular Effects of GLP 1 Receptor Agonists
Cardiovascular Effects of GLP 1 Receptor Agonists

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ago...

Glucagon like Peptide

GLP 1 agonists
GLP 1 agonists

The rise of glucagon-like peptide-1 (GLP‑1) receptor agonists (GLP‑1 RAs) such as semaglutide and tirzepatide has transformed modern metabolic medicine. Once used primarily for type 2 diabetes, these drugs are now prescribed widely for obesity, cardiometabolic risk reduction, and metabolic dysfunction more broadly.1 Their effectiveness has been described as unprecedented,2 with some ...

Summary Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that pro-mote glucose-mediated insulin release and are used to treat type 2 diabetes mel-litus and obesity.

Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving
Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving

Safety and Tolerability of Glucagon

Glucagon-like peptide-1 receptor agonists (GLP-1RAs)—along with the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1RA tirzepatide—are widely acknowledged for their efficacy in managing both type 2 diabetes mellitus and obesity, with expanding indications in cardiometabolic risk reduction. While their glycemic, weight-lowering, and cardiovascular benefits are well established ...

Glucagon-like peptide-1 (GLP-1) agonists are a class of medicines used to treat type 2 diabetes by lowering blood sugar levels. Some are used for weight loss in people with obesity.

The Impact of GLP 1 Receptor Agonists on Ocular Disease
The Impact of GLP 1 Receptor Agonists on Ocular Disease

Overview of Translated Article Glucagon Like Peptide 1 Agonists For Treating

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes and obesity, have evolved into multi-organ potential therapeutics due to their pleiotropic effects beyond glycemic control.

The glucagon-like peptide-1 (GLP-1) receptor, known as GLP-1R, is a vital component of the G protein-coupled receptor (GPCR) family and is found primarily on the surfaces of various cell types ...

GLP 1 receptor agonists GLP 1RAs cardiovascular actions
GLP 1 receptor agonists GLP 1RAs cardiovascular actions

Key Details About Translated Article Glucagon Like Peptide 1 Agonists For Treating

This cohort study evaluates glucagon-like peptide-1 (GLP-1) receptor agonist switching patterns and 12-month adherence and persistence among adults with overweight or obesity without diabetes.

Potential Use of GLP 1 and GIP GLP 1 Receptor Agonists for Respiratory
Potential Use of GLP 1 and GIP GLP 1 Receptor Agonists for Respiratory
GLP 1 receptor agonists effects on established and presumed drivers
GLP 1 receptor agonists effects on established and presumed drivers
TrimRX
TrimRX
Diabetes and Coronary Artery Disease PowerPoint Presentation
Diabetes and Coronary Artery Disease PowerPoint Presentation
GLP 1 Agonists FAQ Cardiology Institute
GLP 1 Agonists FAQ Cardiology Institute

The glucagon-like peptide-1 (GLP-1) receptor, known as GLP-1R, is a vital component of the G protein-coupled receptor (GPCR) family and is found primarily on the surfaces of various cell types within the human body. This receptor specifically interacts with GLP-1, a key hormone that plays an integral role in regulating blood glucose levels, lipid metabolism, and several other crucial ...